Detalhe da pesquisa
1.
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.
N Engl J Med
; 387(3): 217-226, 2022 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857659
2.
A unified framework for weighted parametric group sequential design.
Biom J
; 64(7): 1219-1239, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35704510
3.
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.
Lancet
; 396(10265): 1817-1828, 2020 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33278935
4.
Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy Volunteers.
Antimicrob Agents Chemother
; 63(4)2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30745392
5.
Assessment of drug interaction potential between the HCV direct-acting antiviral agents elbasvir/grazoprevir and the HIV integrase inhibitors raltegravir and dolutegravir.
J Antimicrob Chemother
; 74(3): 710-717, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30541077
6.
Pharmacokinetics of elbasvir and grazoprevir in subjects with end-stage renal disease or severe renal impairment.
Eur J Clin Pharmacol
; 75(5): 665-675, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30680407
7.
Human health risk assessment of groundwater arsenic contamination in Jinghui irrigation district, China.
J Environ Manage
; 237: 163-169, 2019 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30784864
8.
Effect of Hepatic Impairment on the Pharmacokinetics of Grazoprevir, a Hepatitis C Virus Protease Inhibitor.
Antimicrob Agents Chemother
; 61(12)2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28947470
9.
Pembrolizumab plus chemotherapy in triple-negative breast cancer - Authors' reply.
Lancet
; 398(10294): 24-25, 2021 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34217393
10.
No clinically meaningful pharmacokinetic interaction between the hepatitis C virus inhibitors elbasvir and grazoprevir and the oral contraceptives ethinyl estradiol and levonorgestrel.
Eur J Clin Pharmacol
; 73(5): 593-600, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28233047
11.
Consideration of stratification in confirmatory trials with time-to-event endpoint.
Contemp Clin Trials
; 141: 107434, 2024 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215875
12.
Polymerization of Allyltrimethylisilane and 4-Methyl-1-Pentene by Using Metallocene Catalysts.
Polymers (Basel)
; 15(9)2023 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37177185
13.
Fibrous dressing containing bioactive glass with combined chemotherapy and wound healing promotion for post-surgical treatment of melanoma.
Biomater Adv
; 149: 213387, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990026
14.
Health-Related Quality of Life With Pembrolizumab+Chemotherapy Versus Placebo+Chemotherapy for Advanced Triple-Negative Breast Cancer: KEYNOTE-355.
J Natl Cancer Inst
; 2023 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38070159
15.
Efficient and Ultrafast Adsorption of Rhenium by Functionalized Hierarchically Mesoporous Silica: A Combined Strategy of Topological Construction and Chemical Modification.
ACS Appl Mater Interfaces
; 13(7): 8249-8262, 2021 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33569945
16.
Evaluation of Pharmacokinetic Drug Interactions of the Direct-Acting Antiviral Agents Elbasvir and Grazoprevir with Pitavastatin, Rosuvastatin, Pravastatin, and Atorvastatin in Healthy Adults.
Clin Drug Investig
; 41(2): 133-147, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33527237
17.
Pharmacogenetic Analysis of OATP1B1, UGT1A1, and BCRP Variants in Relation to the Pharmacokinetics of Letermovir in Previously Conducted Clinical Studies.
J Clin Pharmacol
; 59(9): 1236-1243, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31022310
18.
Selective Separation of Pd(II) on Pyridine-Functionalized Graphene Oxide Prepared by Radiation-Induced Simultaneous Grafting Polymerization and Reduction.
ACS Appl Mater Interfaces
; 11(27): 24560-24570, 2019 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31250630
19.
The pharmacogenetics of OATP1B1 variants and their impact on the pharmacokinetics and efficacy of elbasvir/grazoprevir.
Pharmacogenomics
; 20(9): 631-641, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31250727
20.
Pharmacokinetic Interactions Between the Fixed-Dose Combinations of Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine and Elbasvir/Grazoprevir in Healthy Adult Participants.
Clin Pharmacol Drug Dev
; 8(7): 952-961, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31173673